Company: SWKH
Filing Date: 2025-03-20
Form Type: 10-K
Source: 0001628280-25-013989
Chunk: 155

Company: SWK Holdings Corp
Filing Date: 2025-03-20
Form: 10-K
Item: Item 8
Chunk 155
---
s and expenses:Provision for credit losses12,756 1,912 Loss on impairment of intangible assets5,771 — Impairment of goodwill— 8,404 Interest expense4,685 1,849 Pharmaceutical manufacturing, research and development expense2,203 3,436 Change in fair value of acquisition-related contingent consideration(4,900)(6,300)Depreciation and amortization expense1,399 2,577 General and administrative expense11,487 11,232 Income from operations11,586 14,650 Other income (expense), netUnrealized net gain (loss) on warrants2,406 (55)Net gain (loss) on exercise and cancellation of warrants445 (799)Net loss on marketable investments(266)— Realized gain on early payment of finance receivable1,065 — Gain on revaluation of finance receivable2,495 — Realized and unrealized foreign currency transaction gains641 817 Income before income tax expense (benefit)18,372 14,613 Income tax expense (benefit)4,884 (1,274)Net income$13,488 $15,887 Net income per shareBasic$1.09 $1.26 Diluted$1.08 $1.25 Weighted average shares outstandingBasic 12,369 12,653 Diluted12,451 12,696 

See accompanying notes to the consolidated financial statements.

35

SWK HOLDINGS CORPORATION

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(In thousands, except share data)

Common StockAdditional Paid-In CapitalAccumulated DeficitTotal Stockholders' EquitySharesAmountBalances at December 31, 202212,843,157 $12 $4,430,922 $(4,151,005)$279,929 Stock-based compensation— — 509 — 509 Issuance of restricted common stock29,978 — — — — Effect of adoption of ASU 2016-13— — — (9,683)(9,683)Stock options exercised, net461 — — — — Repurchases of common stock in open market(375,826)— (6,327)— (6,327)Net income— —